Evidence map›Paper›PMID 38282729›Full record

ArticleFrontiers in microbiology2023

Convergence of plasmid-mediated Colistin and Tigecycline resistance in

Yujie Zhao, Changrui Qian, Jianzhong Ye, Qingcao Li, Rongqing Zhao, Ling Qin, Qifeng Mao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Mobile genetic elements inJournal of bacteriology · 2025
    Review
  4. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
  5. Article
  6. The First Case of Antimicrobial-ResistantInfection and drug resistance · 2025
    Article
  7. Meropenem/vaborbactam activity against carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  8. Acquisition and Transmission ofInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yujie ZhaoDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital, Ningbo University, Ningbo, China.
Changrui QianDepartment of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jianzhong YeDepartment of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qingcao LiDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital, Ningbo University, Ningbo, China.
Rongqing ZhaoDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital, Ningbo University, Ningbo, China.
Ling QinDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital, Ningbo University, Ningbo, China.
Qifeng MaoDepartment of Clinical Laboratory, Ningbo No. 2 Hospital, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The co-occurrence of colistin and tigecycline resistance genes in Methods: Results: WGS and bioinformatic analysis showed that K82 belonged to the ST656 sequence type and carried multiple drug resistance genes, including Conclusion: Our research expands the known diversity of CoRG and TRG-harboring plasmids in

Indexed as

colistinMCR-1plasmidtigecyclinetmexCD1-toprJ1

Identifiers

PMID38282729
PMCPMC10813211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.